Chiara Gorrini

Dr. Chiara Gorrini


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 June 2021 in Frontiers in Oncology
Verified
Journal Article
Open access
PDF file
SSSumana Shrestha
Sumana Shrestha
AMAlaide Morcavallo
Alaide Morcavallo
CGChiara Gorrini
Chiara Gorrini
LCLouis Chesler
Louis Chesler
The constitutive and dysregulated expression of the transcription factor MYCN has a central role in the pathogenesis of the paediatric brain tumour medulloblastoma, with an increased expression of this oncogene correlating with a worse prognosis. Consequently, the genomic and functional alterations of MYCN represent a major therapeutic target to attenuate tumour growth in medulloblastoma. This review will provide a comprehensive synopsis of the biological role of MYCN and its family components, their interaction with distinct signalling pathways, and the implications of this network in medulloblastoma development. We will then summarise the current toolbox for targeting MYCN and highlight novel therapeutic avenues that have the potential to results in better-tailored clinical treatments.

3 November 2021 in Breast Cancer Research and Treatment
Verified
Journal Article
Closed access
PDF file
BWBrooke E. Wilson
Brooke E. Wilson
CGChiara Gorrini
Chiara Gorrini
DCDavid W. Cescon
David W. Cescon